Logo image of ZEN.CA

ZENTEK LTD (ZEN.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:ZEN - CA98942X1024 - Common Stock

1 CAD
0 (0%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ZEN scores 3 out of 10 in our fundamental rating. ZEN was compared to 16 industry peers in the Health Care Equipment & Supplies industry. While ZEN seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ZEN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ZEN has reported negative net income.
In the past year ZEN has reported a negative cash flow from operations.
ZEN had negative earnings in each of the past 5 years.
ZEN had a negative operating cash flow in each of the past 5 years.
ZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

With a decent Return On Assets value of -48.58%, ZEN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
ZEN has a Return On Equity of -70.13%. This is amongst the best in the industry. ZEN outperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA -48.58%
ROE -70.13%
ROIC N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ZEN.CA Yearly ROA, ROE, ROICZEN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

The Gross Margin of ZEN (48.67%) is comparable to the rest of the industry.
ZEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEN.CA Yearly Profit, Operating, Gross MarginsZEN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

4

2. Health

2.1 Basic Checks

ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZEN has been increased compared to 1 year ago.
The number of shares outstanding for ZEN has been increased compared to 5 years ago.
ZEN has a better debt/assets ratio than last year.
ZEN.CA Yearly Shares OutstandingZEN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ZEN.CA Yearly Total Debt VS Total AssetsZEN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 3.44 indicates that ZEN is not in any danger for bankruptcy at the moment.
ZEN has a Altman-Z score of 3.44. This is amongst the best in the industry. ZEN outperforms 100.00% of its industry peers.
ZEN has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
ZEN has a better Debt to Equity ratio (0.15) than 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 3.44
ROIC/WACCN/A
WACC7.78%
ZEN.CA Yearly LT Debt VS Equity VS FCFZEN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M 40M

2.3 Liquidity

ZEN has a Current Ratio of 0.79. This is a bad value and indicates that ZEN is not financially healthy enough and could expect problems in meeting its short term obligations.
ZEN has a better Current ratio (0.79) than 62.50% of its industry peers.
A Quick Ratio of 0.53 indicates that ZEN may have some problems paying its short term obligations.
ZEN has a Quick ratio (0.53) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.53
ZEN.CA Yearly Current Assets VS Current LiabilitesZEN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.08% over the past year.
Looking at the last year, ZEN shows a very strong growth in Revenue. The Revenue has grown by 2223.10%.
The Revenue has been growing by 35.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZEN.CA Yearly Revenue VS EstimatesZEN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 5M 10M
ZEN.CA Yearly EPS VS EstimatesZEN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2023 2024 -0.05 -0.1 -0.15

0

4. Valuation

4.1 Price/Earnings Ratio

ZEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEN.CA Price Earnings VS Forward Price EarningsZEN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEN.CA Per share dataZEN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ZENTEK LTD

TSX-V:ZEN (12/24/2025, 7:00:00 PM)

1

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12
Earnings (Next)02-11 2026-02-11
Inst Owners1.71%
Inst Owner ChangeN/A
Ins Owners0.78%
Ins Owner ChangeN/A
Market Cap107.31M
Revenue(TTM)915.30K
Net Income(TTM)-8.20M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 117.24
P/FCF N/A
P/OCF N/A
P/B 9.18
P/tB 9.18
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.01
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.58%
ROE -70.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.67%
FCFM N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 88.48%
Cap/Sales 54.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.53
Altman-Z 3.44
F-Score4
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)182.79%
Cap/Depr(5y)454.82%
Cap/Sales(3y)1708.52%
Cap/Sales(5y)12638%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.4%
OCF growth 3YN/A
OCF growth 5YN/A

ZENTEK LTD / ZEN.CA FAQ

Can you provide the ChartMill fundamental rating for ZENTEK LTD?

ChartMill assigns a fundamental rating of 3 / 10 to ZEN.CA.


What is the valuation status for ZEN stock?

ChartMill assigns a valuation rating of 0 / 10 to ZENTEK LTD (ZEN.CA). This can be considered as Overvalued.


Can you provide the profitability details for ZENTEK LTD?

ZENTEK LTD (ZEN.CA) has a profitability rating of 2 / 10.